[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

5 clusters · 29 sources · 11 days · First seen · Last updated

Research into new obesity treatment mechanisms

Overview

Researchers at UC Berkeley have identified a molecular compound, 5-tetradecyloxy-2-furoic acid (TOFA), which may offer a new approach to treating obesity and diabetes. Unlike existing GLP-1 medications that primarily suppress appetite, TOFA targets energy expenditure.

In mouse trials, the compound helped burn fat by activating specific receptors and blocking lipid production, resulting in weight loss through fat loss rather than muscle loss. Studies involving overweight mice showed that TOFA administration led to an approximately 18 percent reduction in body weight over a four-week period, even when caloric consumption remained unchanged. The compound achieves this through a dual mechanism: inhibiting the synthesis of new fat by blocking key enzymes while simultaneously stimulating fat burning.

Subsequent findings suggest that TOFA could potentially serve as a complementary therapy to existing treatments. Animal trials indicated that combining TOFA with semaglutide or tirzepatide produced greater weight-loss results than either treatment alone. Additionally, research from Yale University has provided further insight into obesity treatment by discovering that AgRP neurons may play a role in maintaining fat loss during medication use.

Newer research published in Science Advances details that TOFA works by activating PPARα and PPARδ receptors to encourage cells to burn fat for energy. In studies involving obese mice, the molecule increased caloric expenditure by up to 18% without additional physical movement. This mechanism also improved insulin sensitivity, lowered triglycerides, and reduced signs of fatty liver. While these metabolic benefits are significant, researchers emphasize that results are currently limited to animal models and human testing is required to determine safety, effectiveness, and appropriate dosage.

Entities

University of California, Berkeley · TOFA · Anders Näär · Science Advances · UC Berkeley

Timeline

  1. 11 days ago

    [HEALTH] 3 sources
    Researchers identify new metabolic approach to obesity treatment

    Scientists have identified a new molecule, TOFA, that may treat obesity by accelerating metabolism rather than suppressing appetite, while experts discuss the growing impact of weight-loss drugs in Central and려

  2. 16 days ago

    [HEALTH] 10 sources
    University of California researchers find compound TOFA aids fat loss

    University of California researchers found that the compound TOFA helps obese mice lose fat by increasing energy expenditure without reducing food intake or losing muscle mass.

  3. 19 days ago

    [HEALTH] 6 sources
    University of California researchers identify molecule to prevent muscle loss during weight loss

    Researchers at UC Berkeley have identified the TOFA molecule, which may allow for weight loss without muscle loss by increasing fat burning, potentially working synergistically with drugs like semaglutide.

  4. 19 days ago

    [HEALTH] 7 sources
    Researchers identify new mechanisms and compounds for weight loss

    New studies from UC Berkeley and Yale University reveal potential breakthroughs in weight loss, including a compound to prevent muscle loss and new insights into how GLP-1 drugs affect brain neurons.

  5. 21 days ago

    [HEALTH] 2 sources
    UC Berkeley researchers identify potential obesity treatment TOFA

    UC Berkeley researchers have discovered that the compound TOFA may help burn fat and treat obesity in mice without the muscle loss or appetite suppression associated with GLP-1 drugs like Ozempic.

Sources

e15.cz · europa.pravda.sk · exame.com · expansion.com · fehmarn24.de · g4media.ro · gaetanews24.it · imfarmacias.es · immedicohospitalario.es · insalutenews.it · interez.sk · lapresse.it · larazon.es · latercera.com · leinetal24.de · magazin.aktualne.cz · mannheim24.de · microbiologiaitalia.it · news18.com · oxfordhealthbrc.nihr.ac.uk · praha.e15.cz · psychiatrietogo.de · que.es · tech.everyeye.it · time.news · timeskuwait.com · trendsderzukunft.de · tz-online.de · unilad.com

This summary has been updated 4 times: see revision history